The CD58-CD2 Axis Is Co-Regulated with PD-L1 via CMTM6 and Shapes Anti-Tumor Immunity

Investigators found that intact cancer cell-intrinsic expression of CD58 and ligation to CD2 was required for anti-tumor immunity and was predictive of treatment response.